Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 15-17, January 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, S. E.
Right arrow Articles by Stehlin, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, S. E.
Right arrow Articles by Stehlin, J. S., Jr.

Free Amino Acids and Related Compounds in the Blood and Urine of Patients with Malignant Melanoma

Sue Ellen Young, A. Clark Griffin, Alice N. Milner and John S. Stehlin, Jr.1

Departments of Biochemistry and Surgery, The University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Texas

The concentrations of 22 free amino acids in plasma from 12 normal subjects and 10 patients with malignant melanoma were determined by ion exchange chromatography. There were no statistically significant differences between the 2 groups. Twenty-four-hr urine specimens from 15 normal individuals and 13 patients with disseminated melanoma were analyzed for 32 free amino acids or related compounds. In contrast to the plasma findings there were some changes in the urinary excretion of several free amino acids by patients with advanced melanoma. However, the excretion of tyrosine and phenylalanine, the amino acids of direct interest in this study, remains normal. The most significant difference was observed in the excretion of 1-methyl histidine (P < 0.001), in which the average value of patients with melanoma was approximately one-fourth that of normal.

1 This investigation was supported by grants (CA-2620-07, C-5831-10) from the NIH.

Received 5/16/66. Accepted 7/ 7/66.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.